A Study of NGM120 in People With Colorectal Cancer and Cancer Cachexia

Full Title

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of NGM120 in Participants with Colorectal Cancer who have Cancer Cachexia

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Maliha Nustrat’s office at 646-888-6872.

Protocol
26-044
Phase
Phase II (phase 2)
Disease Status
Relapsed or Refractory
Investigator
Maliha Nusrat
Co-Investigators
Puneeth Iyengar
Diseases
Colorectal Cancer
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT07033026
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description